| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |